Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.64
+0.240010.00%
Post-market: 2.650.0100+0.38%18:59 EDT
Volume:3.41M
Turnover:8.89M
Market Cap:415.92M
PE:5.44
High:2.71
Open:2.46
Low:2.43
Close:2.40
Loading ...

CytomX Therapeutics Inc - Regains Compliance With Nasdaq Minimum Bid Price - SEC Filing

THOMSON REUTERS
·
29 May

CytomX Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
20 May

CytomX Therapeutics announces first patient dosed in Phase 1 study of CX-801

TIPRANKS
·
19 May

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of Cx-801 Plus Keytruda® (Pembrolizumab) in Patients With Metastatic Melanoma

THOMSON REUTERS
·
19 May

CytomX Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
16 May

HC Wainwright Upgrades CytomX Therapeutics to Buy From Neutral, Price Target is $5

MT Newswires Live
·
15 May

CytomX Therapeutics Raised to Buy From Neutral by HC Wainwright & Co.

Dow Jones
·
15 May

CytomX Therapeutics Inc : Piper Sandler Raises Target Price to $5 From $2.5

THOMSON REUTERS
·
15 May

Sector Update: Health Care Stocks Climb Monday Afternoon

MT Newswires Live
·
13 May

CytomX Shares Jump After Q1 Beat, 'Positive' Interim Trial Data

MT Newswires Live
·
12 May

CytomX Therapeutics Inc : Wedbush Raises Target Price to $6 From $5

THOMSON REUTERS
·
12 May

Wedbush Adjusts CytomX Therapeutics Price Target to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
12 May

Top Premarket Gainers

MT Newswires Live
·
12 May

Press Release: CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

Dow Jones
·
12 May

CytomX Therapeutics Reports Positive Interim Phase 1 Data

TIPRANKS
·
12 May

CytomX Therapeutics Q1 EPS $0.27 Beats $0.12 Estimate, Sales $50.92M Beat $30.84M Estimate

Benzinga
·
12 May

North American Morning Briefing: Stock Futures Surge on China Deal

Dow Jones
·
12 May

CytomX Therapeutics Inc expected to post earnings of 12 cents a share - Earnings Preview

Reuters
·
09 May

Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock?

Zacks
·
05 May

Press Release: CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

Dow Jones
·
05 May